Csenge Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $927K | Sell |
2,096
-85
| -4% | -$37.6K | 0.05% | 278 |
|
|
2025
Q1 | $1.07M | Buy |
2,181
+37
| +2% | +$18.1K | 0.06% | 243 |
|
|
2024
Q4 | $863K | Sell |
2,144
-828
| -28% | -$333K | 0.05% | 294 |
|
|
2024
Q3 | $1.43M | Sell |
2,972
-430
| -13% | -$207K | 0.07% | 201 |
|
|
2024
Q2 | $1.59M | Buy |
3,402
+638
| +23% | +$299K | 0.09% | 170 |
|
|
2024
Q1 | $1.16M | Buy |
2,764
+258
| +10% | +$108K | 0.06% | 233 |
|
|
2023
Q4 | $1.02M | Buy |
2,506
+439
| +21% | +$179K | 0.06% | 234 |
|
|
2023
Q3 | $719K | Buy |
2,067
+114
| +6% | +$39.6K | 0.05% | 281 |
|
|
2023
Q2 | $687K | Buy |
1,953
+223
| +13% | +$78.5K | 0.05% | 299 |
|
|
2023
Q1 | $545K | Buy |
1,730
+342
| +25% | +$108K | 0.04% | 320 |
|
|
2022
Q4 | $401K | Buy |
1,388
+178
| +15% | +$51.4K | 0.03% | 398 |
|
|
2022
Q3 | $350K | Buy |
+1,210
| New | +$350K | 0.03% | 423 |
|
|
2018
Q4 | – | Sell |
-51
| Closed | -$8K | – | 1461 |
|
|
2018
Q3 | $8K | Buy |
+51
| New | +$8K | ﹤0.01% | 551 |
|